According to the American Cancer Society, more than 61,500 new cases of kidney cancer are expected in 2015. In recognition of National Kidney Cancer Awareness Month, Columbus CyberKnife encourages patients and their loved ones to learn about the disease and treatment options.
Results from a recent study completed by a team of researchers affiliated with the University of Pittsburgh Cancer Institute provides rationale for a national clinical trial to assess the effectiveness of adding head and neck screening to lung cancer screening programs.
Metastatic cancer occurs when cancer cells in the primary tumor site break off and spread to other parts of the body via the blood or lymphatic system. View the presentation for an overview of metastatic cancer and the CyberKnife® treatment approach.
February is National Cancer Prevention Month, a time to promote education around preventive measures and lifestyle tips that may reduce the chance of a cancer occurrence.
The Centers for Medicare and Medicaid Services (CMS) recently announced that screenings for lung cancer with low dose computed tomography (LDCT) will now be covered by Medicare. The coverage is effective immediately.
With a goal of raising awareness of cancer, prevention methods and treatment options, February 4 is recognized annually as World Cancer Day.
The American Cancer Society recently released its 2015 Facts & Figures Report, an annual publication that provides estimated cancer statistics for the year ahead. The infographic below outlines projected numbers of new lung and prostate cancer cases and total estimated new cases in the state of Ohio and the U.S. If you or a loved one receives a cancer diagnosis this year, contact Columbus CyberKnife to learn about our noninvasive treatment approach.
For many cancer survivors, the thought of a possible recurrence can weigh heavily on the mind after completing treatment. Although the risk of recurrence is different for each person and depends on many factors, the steps below are some actions survivors can take to improve their chances of detecting a recurrence early and increasing their chances of survival.
While 65 percent of prostate cancers are diagnosed in men over the age of 65, men much younger than that age group are still at risk for developing early-onset prostate cancer, the distinct type of the disease that affects men under the age of 55.
Columbus CyberKnife treats a variety of malignant and benign tumors with a specialized form of radiation therapy called stereotactic body radiation therapy (SBRT).